Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

a study on Quality of Life

Summary

Eligibility
for people ages 5 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCSF
Dates
study started
estimated completion
Principal Investigator
by Christopher Dvorak, MD (ucsf)
Headshot of Christopher Dvorak
Christopher Dvorak

Description

Summary

To compare donors to their non-donor counterparts and healthy controls as well as to generate trajectory classes based on longitudinal patterns of donor HRQoL and identify predictors of poor donor HRQoL.

Details

There is limited data to show the effects that donation has on pediatric donors to their siblings. There is widespread agreement that it is critical to investigate the medical and psychosocial aspects of sibling pediatric HSC donation for multiple reasons including (a) the vulnerability of the pediatric population undergoing donation, (b) increasing use of pediatric HSC donation as a therapeutic option, (c) evidence that ~20% of pediatric HSC donors experience clinically important HRQoL deficits, and (d) the impact that improved understanding of factors predicting poor HRQoL will have on our ability to develop guidelines and/or interventions for assisting at-risk donors/families. The proposed study will help to compare donors to their non-donor counterparts and healthy controls as well as to generate trajectory classes based on longitudinal patterns of donor HRQoL and identify predictors of poor donor HRQoL.

Keywords

Quality of Life Sibling pediatric donors Sibling recipients and caregivers Parents

Eligibility

You can join if…

Open to people ages 5 years and up

  • Participants must fall into one of the following categories:
  • Donor between the age of 5 and 17 who is donating to a sibling
  • Parent/caregiver of study participating donor
  • Recipient sibling aged 5 to 17 of study participating donor
  • Any of the donor's non-donor/non-recipient siblings between 5 and 17
  • Any child between 5 and 17 with a brother or sister (also between 5 and 17) receiving a transplant from an unrelated source
  • Be willing and able to provide signed informed consent:
  • Adults must give consent for their children's and, if applicable, their own participation
  • Assent will be obtained in accordance with guidelines at the participant's transplant institution
  • Be willing and able to respond to psychological assessment questions
  • Must be the donor's first donation
  • Recipient must consent to the CIBMTR research database

You CAN'T join if...

  • For families with pediatric donors aged 5 to 17, at minimum, the donor child and/or one parent must consent/assent to participation. If that minimum is not met, the family will be excluded
  • Donor or non-donor siblings who do not live in the same household as the recipient at lease half of the time
  • Unable to consent/assent or complete a phone interview in English
  • Parents may consent/assent in Spanish
  • No access to a telephone

Locations

  • University of California San Francisco Medical Center accepting new patients
    San Francisco California 94143 United States
  • Rady Children's Hospital San Diego accepting new patients
    San Diego California 92123 United States
  • Children's Hospital of Los Angeles accepting new patients
    Los Angeles California 90027 United States
  • City of Hope accepting new patients
    Duarte California 91010 United States

Lead Scientist at University of California Health

  • Christopher Dvorak, MD (ucsf)
    My Research Interests are divided into 3 areas of focus: 1. Supportive Care (especially Invasive Fungal Infections) following Hematopoietic Stem Cell Transplantation 2. Transplantation for Severe Combined Immunodeficiency 3. Transplantation for Rare Leukemias (JMML and APL)

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Center for International Blood and Marrow Transplant Research
ID
NCT03718546
Study Type
Observational
Participants
Expecting 1876 study participants
Last Updated